GlassScriptPhysician profile
David K Yoon
NPI 1558437707
$3,254.19
in general payments reported to CMS, 2019-2025
34 companies · $85.00 in 2025
The $85.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $630 · 2020: $527 · 2021: $651 · 2022: $286 · 2023: $510 · 2024: $565 · 2025: $85.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $641.46 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $411.38 | 2022-2024 | Trelegy Ellipta |
| Amgen INC. | $366.22 | 2019-2024 | Prolia, Evenity, Otezla |
| Pfizer INC. | $265.11 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $252.76 | 2019-2024 | |
| Abbvie INC. | $186.93 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $110.97 | 2020-2023 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.97 | 2023-2024 | Jardiance |
| Lilly USA, LLC | $80.86 | 2021-2023 | Jardiance |
| Abbott Laboratories | $78.25 | 2022-2023 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $71.55 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $67.16 | 2019-2023 | Verquvo |
| Hikma Pharmaceuticals USA | $63.84 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $60.82 | 2020 | |
| Sunovion Pharmaceuticals INC. | $53.77 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $53.76 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.18 | 2024 | |
| Ibsa Pharma INC. | $34.24 | 2021 | |
| Atricure, INC. | $32.51 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.03 | 2019 | |
| Medtronic, INC. | $27.30 | 2024 | Cobalt Dr Mri Surescan |
| Arbor Pharmaceuticals, INC. | $25.58 | 2019-2020 | |
| Philips North America LLC | $22.05 | 2025 | Extended Holter |
| Exact Sciences Corporation | $22.01 | 2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $20.90 | 2024 | Farxiga |
| Almatica Pharma LLC | $20.78 | 2024 | Loreev Xr |
| Eisai INC. | $19.07 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.78 | 2020 | |
| Tolmar, INC. | $17.27 | 2025 | Jatenzo |
| Eyevance Pharmaceuticals LLC | $15.78 | 2021 | |
| Idorsia Pharmaceuticals US INC | $15.31 | 2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $15.19 | 2020 | |
| Allergan, INC. | $13.77 | 2021 | |
| Medicomp INC | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Yoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.